Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04586088 |
|---|---|
| Brief Title: | Apatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment Failure |
| First Submitted : | October 7, 2020 |
| First Submitted that Met QC Criteria : | October 7, 2020 |
| First Posted : | October 14, 2020 |
| Last Update Submitted that Met QC Criteria : | May 3, 2023 |
| Last Update Posted : | May 6, 2023 |